These two effects were not observed during B2R agonist treatment at the same dosage and by the same route in mice non-submitted to cerebral ischemia or in other experimental settings, including in diabetes, ruling out renal toxicity of the B2R agonist12, 35 (unreported data). Here, BDKRB2 is linked to diabetes mellitus.